Skip to content
Screener

Progyny PGNY Business Segments — Net Income

Similar metrics at other companies

BridgeBio Pharma logo
BBIOReportable Segment — Net Income (Loss) Attributable to Noncontrolling Interest
-$2.51M-14.9%
Dolby Laboratories, Inc. logo
DLBReportable Segment — Net Income (Loss) Attributable to Noncontrolling Interest
$539K+24.5%
Open Text logo
OTEXReportable Segment — Net Income (Loss) Attributable to Noncontrolling Interest
$61K+19.6%
OppFi logo
OPFIReportable Segment — Less: net income attributable to noncontrolling interest
$25.64M-19.3%
Douglas Elliman logo
DOUGOne Reportable Segment — Net Income (Loss) Attributable to Noncontrolling Interest
$0+100%
PNW
PNWReportable Segment — Less: Net income attributable to noncontrolling interests (Note 9)
-$2M+50.0%

Other financials

Income statement

See full
Revenue$350.5M+5.3%
Gross profit$89.3M+13.1%
Operating income$40.0M+64.2%
Net income$28.1M+63.9%
EPS (diluted)$0.34+78.9%

Balance sheet

See full
Cash & equivalents$152.6M+15.2%
Total debt$27.0M-5.8%
Total equity$453.3M-12.0%
Total assets$715.8M-5.9%

Cash flow

See full
Operating cash flow$50.4M-9.2%
CapEx$6.2M+18.0%
Free cash flow$44.2M-12.0%

Valuation

See full
Market cap$2.37B+17.5%
Enterprise value$2.24B+17.3%
P/E30.1×-7.8×
P/S1.8×+0.2×

Profitability

See full
Gross margin24.6%+2.2pp
Operating margin8.6%+2.4pp
Net margin6%+1.7pp
FCF margin13.6%-1.7pp

Returns & leverage

See full
Return on equity16.2%+5.3pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.6×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLossAttributableToNoncontrollingInterest.

The source filing: Progyny’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 9:00 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001551306-26-000140
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue(1)$350,511$332,874$679,015$656,912
Less:
Cost of services261,210253,901506,643502,144
Sales and marketing18,07418,40534,95836,191
General and administrative31,22436,21062,03270,049
Interest and other income, net(1,134)(2,719)(2,638)(5,086)
Provision for income taxes13,0859,96525,73621,443
Net income$28,052$17,112$52,284$32,171

Item 1. Financial Statements (Unaudited)

FAQ

What is Progyny's business segments — net income?
Progyny (PGNY) reported business segments — net income of -$28.05M in Q2 2026.
How has Progyny's business segments — net income changed year-over-year?
Progyny's business segments — net income decreased by 63.9% year-over-year, from -$17.11M to -$28.05M.
What is the long-term trend for Progyny's business segments — net income?
Over 3 years (2022 to 2025), Progyny's business segments — net income has grown at a -7.2% compound annual growth rate (CAGR), from $30.36M to $24.3M.
What does business segments — net income mean?
This metric represents the final profit generated by the business segment after accounting for all operating costs, interest, and taxes. It serves as the primary indicator of the segment's overall financial performance and ability to generate value for the organization. A consistent trend in this figure demonstrates the long-term sustainability of the business model.

Ask your AI about Progyny's business segments — net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude